The FDA has approved three self-administered tests for the high-risk strains of HPV known to cause most cervical cancers.

One of the first tests that allows patients to self-collect samples to screen for human papillomavirus (HPV) will soon be available in doctors' offices. In May, the U.S. Food and Drug Administration ...

Outcomes in HPV-associated oropharyngeal squamous cell carcinoma after postoperative or definitive nonsurgical therapy. Background: Human papillomavirus (HPV) type 16 is associated with a subset of ...

However, the test for antibodies against HPV16 E6 is not suitable for assessing the risk for cervical cancer and other HPV-associated cancers in genital areas. As opposed to cancer of the oropharynx, ...

Can We Define Protection by Analyzing Natural Responses to HPV? It should be noted, however, that the aforementioned studies rely on the definition of HPV-negative status. The infection status of a ...

LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single-dose HPV vaccine schedule could improve ...